Abstract
This case study focuses on a 21-year-old woman with a history of obesity and a psychiatric
history of chronic persistent depression since high school seeking alternative treatments
for her depression and her depressive-related weight issues. The discussion explores
issues of depression and the associated weight concerns with treatment options in
the adult patient. The client was prescribed bupropion and naltrexone to manage her
depression and eating behaviors that contributed to her obesity. This article reviews
the effects of depression on appetite and methods of managing both comorbidities.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal for Nurse PractitionersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Diagnostic and Statistical Manual of Mental Disorders.7th ed. APA, 2019
- Eating disorders. 2016.
- Tryptophan metabolic pathways and brain serotonergic activity: a comparative review.Front Endocrinol (Lausanne). 2019; 10: 158https://doi.org/10.3389/fendo.2019.00158
- Improving therapeutics in anorexia nervosa with tryptophan.Life Sci. 2017; 178: 87-93https://doi.org/10.1016/j.lfs.2017.04.015
- Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.Obes Res. 2001; 9: 544-551https://doi.org/10.1038/oby.2001.71
- Pharmacologic treatment of eating disorders.Psychiatr Clin North Am. 2019; 42: 253-262https://doi.org/10.1016/j.psc.2019.01.007
- The relationship between bupropion and suicide in post-mortem investigations.Forensic Sci Int. 2016; 266: 343-348https://doi.org/10.1016/j.forsciint.2016.06.026
- Psychopharmacological advances in eating disorders.Expert Rev Clin Pharmacol. 2018; 11: 95-108https://doi.org/10.1080/17512433.2018.1383895
- Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives.Psychol Res Behav Manag. 2017; 10: 165-172https://doi.org/10.2147/PRBM.S113278
- Pharmacotherapy of depression in old age.Acta Clin Belg. 2005; 60: 150-156https://doi.org/10.1179/acb.2005.028
- Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.BMJ. 2019; 365: I1476https://doi.org/10.1136/bmj.11476
- The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.Am J Psychiatry. 2011; 168: 1266-1277https://doi.org/10.1176/appi.ajp.2011.10111704
- The role of depression, eating disorder symptoms, and exercise in young adults’ quality of life.Eat Behav. 2018; 31: 68-73https://doi.org/10.1016/j.eatbeh.2018.08.005
- Exercise in eating disorders treatment: systematic review and proposal of guidelines.Med Sci Sports Exerc. 2016; 48: 1408-1414https://doi.org/10.1249/MSS.0000000000000912
Biography
Ann Lurati, DNP, MPH, AGACNP, is a nursing lecturer at California State University in Monterey Bay and can be contacted at [email protected]
Article info
Publication history
Published online: April 12, 2022
Footnotes
In compliance with standard ethical guidelines, the author reports no relationships with business or industry that would pose a conflict of interest.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
